Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 4,332 | 1,373 | 800 | 800 | 667 |
| Gross Profit | 4,332 | 1,373 | 800 | 800 | 667 |
| Operating Expenses | 124,432 | 44,872 | 58,513 | 102,969 | 72,067 |
| Operating Income | -120,100 | -43,499 | -57,713 | -102,169 | -71,400 |
| Other Income | 12 | 11,718 | 606 | 6,037 | 7,622 |
| Pre-tax Income | -120,088 | -31,781 | -57,107 | -96,132 | -63,778 |
| Net Income Continuous | -120,088 | -31,781 | -57,107 | -96,132 | -63,778 |
| Net Income | $-120,088 | $-31,781 | $-57,107 | $-96,132 | $-63,778 |
| EPS Basic Total Ops | -143.93 | -46.48 | -98.95 | -182.91 | -145.43 |
| EPS Basic Continuous Ops | -143.56 | -47.11 | -99.62 | -183.49 | -144.87 |
| EPS Diluted Total Ops | -143.93 | -46.48 | -98.95 | -182.91 | -145.43 |
| EPS Diluted Continuous Ops | -143.56 | -47.11 | -99.62 | -183.49 | -144.87 |
| EBITDA(a) | $-119,743 | $-43,037 | $-56,975 | $-101,511 | $-71,132 |